SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-22-000012
Filing Date
2022-05-04
Accepted
2022-05-04 06:04:52
Documents
78
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20220331.htm   iXBRL 10-Q 1770743
2 EX-10.1 uthrex10103312022.htm EX-10.1 32403
3 EX-31.1 uthrex31103312022.htm EX-31.1 11700
4 EX-31.2 uthrex31203312022.htm EX-31.2 11706
5 EX-32.1 uthrex32103312022.htm EX-32.1 6566
6 EX-32.2 uthrex32203312022.htm EX-32.2 6693
  Complete submission text file 0001082554-22-000012.txt   8275911

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20220331.xsd EX-101.SCH 53195
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20220331_cal.xml EX-101.CAL 74621
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20220331_def.xml EX-101.DEF 304935
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20220331_lab.xml EX-101.LAB 704853
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20220331_pre.xml EX-101.PRE 458702
72 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20220331_htm.xml XML 1442858
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 22889685
SIC: 2834 Pharmaceutical Preparations